Under-recognition of chronic kidney disease in elderly outpatients

Clinical Nephrology

Volumn 68, Issue 6, 2007, Pages 373-378

  Ouseph, R ^a   Hendricks, P ^b   Hollon, J A ^a   Bhimani, B D ^a   Lederer, E D ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Elderly; Glomerular filtration rate; MDRD formula

Indexed keywords

ERYTHROPOIETIN; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ANEMIA; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG USE; ELDERLY CARE; ELECTRONIC MEDICAL RECORD; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; RETROSPECTIVE STUDY; UNITED STATES;

EID: 37149002078     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp68373     Document Type: Article

References (41)

1. Akbari A, Swedko PF, Clark HD, Hogg W, Lemelin J, Magner P, Moore L, Ooi D. Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch Intern Med. 2004; 164: 1788-1792.
2. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG. Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population. Kidney Int. 2000; 57: 2072-2079.
3. Collins AJ. Anaemia management prior to dialysis: cardiovascular and cost-benefit observations. Nephrol Dial Transplant. 2003; 18: ii2-ii6.s
4. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey. Am J Kidney Dis. 2003; 41: 1-12.
5. Corsonello A, Pedone C, Corica F Mussi C, Carbonin P, Incalzi RA. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med. 2005; 165: 790-795.
6. Duncan L, Heathcote J, Djurdjev O, Levin A. Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant. 2001; 16: 1042-1046.
7. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb. Cystatin C as a marker of GFR-history, indications, and future research. Clinical Biochemistry. 2005; 38: 1-8.
8. FliserD, Franek E, Joest M, Block S, Mutschler E, Ritz E. Renal function in the elderly: Impact of hypertension and cardiac function. Kidney Int. 1997; 51: 1196-1204.
9. Fliser D. Ren sanus in corpore sano: the myth of the inexorable decline of renal function with senescence. Nephrol Dial Transplant. 2005; 20: 482-485.
10. Glodberg TH, Finkelstein MS. Difficulties in estimating glomerular filtration rate in the elderly. Arch Int Med. 1987; 147: 1430-1433.
11. Go A, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-1305.
12. Harmoinen A, Lehtimaki T Korpela M, Turjanmaa V, Saha H. Diagnostic accuracies of plasma creatinine, cystatin C, and glomerular filtration rate calculated by the Cockcroft-Gault and Levey (MDRD) Formulas. Clinical Chemistry. 2005; 49: 1223-1225.
13. Hu K, Matayoshi A, Stevenson FT. Calculation of the estimated creatinine clearance in avoiding drug dosing errors in the older patient. Am J Med Sci, 2001; 22: 133-136.
14. Hsu C and Chertow GM. Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant. 2002; 17: 1419-1425.
15. John R, Webb M, Young A, Stevens PE. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis. 2004; 43: 825-835.
16. Kee F, Reaney EA, Marwell AP, Fogarty DG, Savage G, Patterson CC. Late referral for assessment of renal failure. J Epidemiology Community Health. 2005; 59: 386-388.
17. Keith DS, Nichols GA, Gullion CM, Brown J8, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intem Med. 2004; 164: 659-663.
18. Khan SS, Xue JL, Kazmi WH, Gilbertson DT, Obrador GT, Pereira BJG, Collins AJ. Does predialysis nephrology care influence patient survival after initiation of dialysis. Kidney Jnt. 2005; 67: 1038-1046.
19. Kurella M, Chertow GM, Fried LF, Cummings SR, Harris T, Simonsick E, Satterflield S, Ayonayon H, Yaffe K. Chronic kidney disease and cognitive impairment in the elderly: The Health, Aging, and Body Composition study. J Am Soc Nephrol. 2005; 16: 2127-2133.
20. Kurella M, Bennett WM, Chertow GM. Analgesia in patients with ESRD: A review of available evidence. Am J Kidney Dis. 2003; 42: 217-228.
21. Lamb EJ, Webb MC, Simpson DE, Coakley Aj, Newman DJ, O'Riordan SE. Estimation of glomerular filtration rate in older patients with chronic renal insufficiency: Is the modification of diet in renal disease formula an improvement? J Am Geriatr Soc, 2003; 51: 1012-1017.
22. Levey AS, Bosch JP Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999; 130: 461-470.
23. Magnason RL, Indridason OS, Sigvaldason H, Sigfusson N, Palsson R. Prevalence and progression of CRF in Iceland: A population-based study. Am J Kidney Dis. 2002; 40: 955-963.
24. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinctics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2003; 57: 6-14.
25. McCellan WM, Ramirez STB, Jurkovitz C. Screening of chronic kidney disease: Unresolved issues. Proceedings of the 1st NKF Singapore summit on the prevention of renal and related diseases. J Am Soc Nephrol. 2003; 14: S76-S80.
26. Motola D, Vacceri A, Silvani MC, Poluzzi E, Botioni A, De Ponti F, Montanaro N. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur J Clin Pharmacol. 2004; 60: 731-738.
27. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis. 2002; 39: S1 -S000.
28. Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJG. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol. 1999; 10: 1793-1800.
29. Odden MC, Whooley MA, Shlipak MG. Association of chronic kidney disease and anemia with physical capacity: The Heart and Soul study. J Am Soc Nephrol. 2004; 15: 2908-2915.
30. Rabenda V, Burlet N, Ethgen O, Raeman F, Belaiche J, Reginster J-Y. A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 2005; 64: 688-693.
31. Rimon E, Kagansky N, Cojocaru L, Gindin J, Schattner A, Levy S. Can creatinine clearance be accurately predicted by formulae in octogenarian inpatients? Q J Med. 2004; 97: 281-287.
32. Roger SD, Mcmahon LP, Clarkson A, Disney A, Harris D, Hawley C, Healy H Kerr P, Lynn K, Parnham A, Pascoe R, Voss D, Walker R, Levin A. Effects of early and late intervention with epoetin a on left ventricular mass arnong patients with chronic kidney disease (Stage 3 or 4): Results of a randomized clinical trial. J Am Soc Nephrol. 2004; 15: 148-156.
33. Sarnak MJ. Cardiovascular complications in chronic kidney disease Am J Kidney Dis. 2003; 41 (Suppl 5): S11-S17.
34. Shlipak MG, FriedL F, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM. Cardiovascular disease risk status in elderly person with renal insufficiency. Kidney Int. 2002; 62: 997-1004.
35. Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, Stark PC, Uhlig K, Van Lente Fevey AS. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: Evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol. 2005; 16: 2439-2448.
36. Swedko PJ, Clark HD, Paramsothy K Akbari A. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med. 2003; 163: 356-360.
37. Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furgerg C, Cobbe S, Simes J, Craven T, West M. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation. 2004. 111: 1557-1565.
38. Van Den Noortgate NJ, Janssens WH, Delanghe JR, Afschrift MB, Lameire NH. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc. 2002; 50: 1278-1282.
39. Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: Influence of age and body mass index Am J Kidney Dis. 2005; 46: 233-241.
40. Wasen E, Raimo I, Matilla K, Vahlberg T, Sirkka-Liisa K, Kerttu I. Renal impairment associated with diabetes in the elderly. Diabetes Care. 2004; 27: 2648-2653.
41. US Census Bureau. US Interim Projections by age, sex, race, and Hispanic origin: http://www.census.gov/ipc/www/usinterimproj/; March 18, 2004.